General Oncology

Survey Responses Reveal Focus of Cancer Survivors’ Pandemic-Related Worries

By

Vicki Moore, PhD

Publish Date March 4, 2021

A survey conducted in the early months of the pandemic revealed cancer survivors’ greatest concerns regarding their care, prognosis, and finances.

COVID-19 Pandemic Hampering Launch of New Oncology Trials

By

Leah Lawrence

Publish Date March 4, 2021

A team of researchers conducted a study to assess the impact of the COVID-19 pandemic on the initiation of clinical trials in oncology.

NCCN Releases COVID-19 Vaccination Recommendations for Cancer Patients

By

Julie Scott, ANP-BC, AOCNP

Publish Date March 3, 2021

As COVID-19 vaccine rollout continues, the NCCN released its preliminary recommendations regarding vaccination administration to patients with cancer.

Preexisting Autoimmune Disease Increases Incidence of irAEs With PD-1 Immunotherapy for Advanced Cancer

By

Katie Kosko

Publish Date March 1, 2021

Study findings demonstrate the rates of immune-related adverse events and flares of the underlying disorders in this patient population.

Janssen’s Single-Shot COVID-19 Vaccine Gets Emergency Use Authorization

By

Diana Ernst, RPh

Publish Date March 1, 2021

The EUA was based on data from the randomized, double-blind, placebo-controlled ENSEMBLE trial.